# West Pharmaceutical Svsc (WST): value investors who own it

1 value investor held West Pharmaceutical Svsc in their Q3 2026 13F, led by Gates Foundation Trust.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Gates Foundation Trust | 0.5% | $160m | Unchanged | 6 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-15 | Favorite Annette F | Sr. VP & Chief HR Officer | Sold | 2524 | $921k |
| 2026-09-14 | Favorite Annette F | Sr. VP & Chief HR Officer | Sold | 2500 | $888k |
| 2026-09-11 | Favorite Annette F | Sr. VP & Chief HR Officer | Sold | 2500 | $863k |
| 2026-09-08 | Favorite Annette F | Sr. VP & Chief HR Officer | Sold | 2818 | $960k |
| 2026-09-08 | Favorite Annette F | Sr. VP & Chief HR Officer | Sold | 2817 | $960k |
| 2026-09-08 | Favorite Annette F | Sr. VP & Chief HR Officer | Sold | 2500 | $852k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/wst). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.